10/07/2014
Federal Register Notice: FDA’s collection of information entitled “Guidance for Industry on User Fee Waivers, Reductio...10/07/2014
Federal Register Notice: FDA is making available guidance for industry entitled Pathological Complete Response in Neoadjuvant Trea...10/02/2014
Federal Register Notice: FDA is making available a guidance: Content of Premarket Submissions for Management of Cybersecurity in M...10/01/2014
Federal Register Notice: FDA is announcing the fee rate at $2,562,000 for using a rare pediatric disease priority review voucher f...09/24/2014
Federal Register Notice: FDA is making available a guidance entitled Custom Device Exemption. The agency defines terms used in the...09/24/2014
Federal Register Notice: FDA is making available Draft Guidance for Industry, Bioequivalence: Blood Level Bioequivalence Study (VI...09/16/2014
Federal Register Notice: FDA is correcting an 8/29 notice entitled “Draft Guidance for Industry: Electronic Submission of Lo...09/10/2014
Federal Register Notice: FDA’s proposed collection of information, “Health and Diet Survey as Used by the Food and Dru...